We use cookies for a better user experience. Read our Privacy Policy
I AgreeChronic burn wounds lead to trauma amongst patients. What adds to the patient’s difficulty is the risk of infection, sepsis, joint problems, and scarring during the management of third-degree burns. Hence, healthcare industries are increasing awareness about amniotic membranes (AM), since these membranes have gained the approval of many health commissions across various countries.
Healthcare providers in the amniotic membrane market are increasingly using fresh amniotic membranes as dressings on burn areas. It has been found that, serology and virology tests validate the use of frozen amnion membrane dressings to minimize the risks of infection transfer. Companies in the amniotic membrane market are increasing the availability of amnion membranes to facilitate the reepithelization of burn wounds. Incremental opportunities related to burn wounds are likely to grow, since the overall surgical wounds domain accounts for the highest revenue amongst all applications in the amniotic membrane market, with a predicted value of ~US$ 1.2 billion by 2027.
The growing trend of amniotic membranes enriched with stem cells is gaining traction in the healthcare landscape. This trend is anticipated to grow even further, since it has been found that, amniotic membrane dressings significantly reduce pain in burn patients.
To know the scope of our report Get a Sample on Amniotic Membrane Market
There is growing demand for human amniotic membranes (hAM) for cardiac tissue regeneration. Hence, healthcare companies in the amniotic membrane market fostering innovation in human-induced pluripotent stem cell (hiPSC)-derived cardiac muscle cells for successful cardiac tissue regeneration. This technique is pervasively becoming a treatment alternative to gelatin-based 3D matrix matrigel protein.
Heart attacks can lead to necrosis of the cardiac tissue. This trend has become a driver for the amniotic membrane market, since increasing rates of heart failures have led to several deaths, worldwide. Individuals are becoming increasingly aware about hAM. Hence, companies in the amniotic membrane market are increasing the availability of hAM in hospitals and ambulatory surgical centers to aid successful regeneration of injured cardiac tissue.
Healthcare companies are focusing on innovation regarding the combination of stem cells and synthetic materials for cardiac tissue regeneration. Decellularized biological matrices are also emerging as a useful alternative for tissue regeneration.
Foot pain is one of the most common orthopedic complaints in the healthcare landscape. To cater to this prevalent health condition, healthcare industries are developing improved amniotic allografts to reduce joint and soft tissue pain. The introduction of amniotic allografts has helped reduce pain and enhance healing in patients suffering from foot and ankle pain.
Growing incidence of repeated trauma and joint pain in the feet has triggered the demand for amniotic allografts. Healthcare providers are providing relief to patients after several clinical trials through musculoskeletal ultrasound, electromyography and computerized tomography scans. Amniotic allografts are becoming increasingly popular amongst patients, since this technique provides long-term relief, unlike the conventional non-operative management of joint pain.
Get a glimpse of the in-depth analysis through our Report Brochure
Locally available amnion mesenchymal cell injections are creating incremental opportunities for healthcare companies, since these injections help in the healing of injured peripheral nerves.
HAAM-based Approach Becomes Increasingly Suitable for Treatment of Skin Wounds
The lower third of the nose is one of the most important cosmetic units as far as the face is concerned. However, reconstruction techniques for the same remain a challenge for healthcare industries in the amniotic membrane space.
Human acellular amniotic membrane (HAAM) implantation serves as an effective approach for lower third nasal reconstruction. Companies in the amniotic membrane market are carrying out extensive investigations to closely study this biomaterial-based strategy. However, in many cases, HAAM leads to full-thickness defects after the surgical procedure. Lack of research studies make it unclear whether the locations of the wound affect the healing potential of HAAM. To overcome these challenges, healthcare industries in the amniotic membrane market are increasing efforts to establish a standardized process for HAAM that can aid its adoption for future clinical use.
Altogether, HAAM is found to have a promising approach for treating various skin defects. Hence, healthcare industries are increasing its application in the amniotic membrane market for repairing skin wounds. They are increasing their R&D efforts to study the safety and efficacy of HAAM for burn wounds and diabetic foot ulcers.
Expanding operations in future? To get the perfect launch ask for a custom report
Analysts’ Viewpoint
The amniotic membrane market is highly consolidated in nature, with only four major players accounting for ~70% of the market share. Companies are increasing their presence in inorganic strategies such as commercializing their product portfolios. For instance, in August 2018, MiMedx - a leader in placental-based products, revealed that it had received regulatory approval to commercialize its product portfolio in dehydrated human amnion/chorion membrane (dHACM) products in Australia.
However, complications associated with amniotic membranes, such as post AM transplantation infection and premature degeneration, are likely to hamper market growth. To win over these hurdles, companies should increase R&D related to the orientation of AM with useful techniques such as sutureless AM in clinical-based setting.
Amniotic Membrane Market and Report Description
Global Amniotic Membrane Market: Drivers
Global Amniotic Membrane Market: Key Segments
Global Amniotic Membrane Market: Competition Analysis
Global Amniotic Membrane Market - Segmentation
TMR’s study on the global amniotic membrane market includes information divided into four segments: product, application, end user, and region. Changing industry trends and other crucial market dynamics associated with these segments of the global amniotic membrane market have been discussed in detail.
Product |
Cryopreserved Amniotic Membrane Lyophilization Amniotic Membrane |
Application |
Surgical Wounds Ophthalmology Others |
End User |
Hospitals Ambulatory Surgical Centers Specialized Clinics Research Centers & Laboratories |
Region |
North America Europe Asia Pacific Latin America Middle East & Africa |
Interested in this report?
Get a FREE Brochure now!
*Get Brochure Report (PDF) sent to your email within minutes
Amniotic membrane market to reach a valuation of ~US$ 2.4 Bn by 2027
Amniotic membrane market to expand at a CAGR of ~10% from 2019 to 2027
Amniotic membrane market is driven by increase in research on amniotic membranes as a regenerative medicine
The cryopreserved amniotic membrane segment dominated the global amniotic membrane market, and the trend is likely to continue during the forecast period
Key players in the global amniotic membrane market include Amnio Technology, LLC, Katena Products, Inc., MiMedx, Skye Biologics, Inc., Integra LifeSciences, Applied Biologics
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Amniotic Membrane Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Amniotic Membrane Market Analysis and Forecast, 2017–2027
5. Key Insights
5.1. Clinical Trial Analysis
5.2. Regulatory Scenario of Amniotic Membrane Products
5.3. Reimbursement Scenario of Amniotic Membrane
6. Global Amniotic Membrane Market Analysis and Forecasts, by Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
6.3.1. Cryopreserved Amniotic Membrane
6.3.2. Lyophilization Amniotic Membrane
6.4. Global Amniotic Membrane Market Attractiveness, by Product
7. Global Amniotic Membrane Market Analysis and Forecasts, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Amniotic Membrane Market Value (US$) Forecast, by Application, 2017–2027
7.3.1. Surgical Wounds
7.3.2. Ophthalmology
7.3.3. Others
7.4. Global Amniotic Membrane Market Attractiveness, by Application
8. Global Amniotic Membrane Market Analysis and Forecasts, by End User
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
8.3.1. Hospitals
8.3.2. Ambulatory Surgical Centers
8.3.3. Specialized Clinics
8.3.4. Research Centers & Laboratories
8.4. Global Amniotic Membrane Market Attractiveness, by End User
9. Global Amniotic Membrane Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Amniotic Membrane Market Attractiveness, by Region
10. North America Amniotic Membrane Market Analysis and Forecast
10.1. Introduction
10.2. North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
10.2.1. Cryopreserved Amniotic Membrane
10.2.2. Lyophilization Amniotic Membrane
10.3. North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
10.3.1. Surgical Wounds
10.3.2. Ophthalmology
10.3.3. Others
10.4. North America Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
10.4.1. Hospitals
10.4.2. Ambulatory Surgical Centers
10.4.3. Specialized Clinics
10.4.4. Research Centers & Laboratories
10.5. North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Country, 2017–2027
10.5.1. U.S.
10.5.2. Canada
10.6. North America Amniotic Membrane Market Attractiveness Analysis
10.6.1. By Product
10.6.2. By Application
10.6.3. By End User
10.6.4. By Country
11. Europe Amniotic Membrane Market Analysis and Forecast
11.1. Introduction
11.2. Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
11.2.1. Cryopreserved Amniotic Membrane
11.2.2. Lyophilization Amniotic Membrane
11.3. Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
11.3.1. Surgical Wounds
11.3.2. Ophthalmology
11.3.3. Others
11.4. Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
11.4.1. Hospitals
11.4.2. Ambulatory Surgical Centers
11.4.3. Specialized Clinics
11.4.4. Research Centers & Laboratories
11.5. Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Amniotic Membrane Market Attractiveness Analysis
11.6.1. By Product
11.6.2. By Application
11.6.3. By End User
11.6.4. By Country/Sub-region
12. Asia Pacific Amniotic Membrane Market Analysis and Forecast
12.1. Introduction
12.2. Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
12.2.1. Cryopreserved Amniotic Membrane
12.2.2. Lyophilization Amniotic Membrane
12.3. Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
12.3.1. Surgical Wounds
12.3.2. Ophthalmology
12.3.3. Others
12.4. Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
12.4.1. Hospitals
12.4.2. Ambulatory Surgical Centers
12.4.3. Specialized Clinics
12.4.4. Research Centers & Laboratories
12.5. Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Amniotic Membrane Market Attractiveness Analysis
12.6.1. By Product
12.6.2. By Application
12.6.3. By End User
12.6.4. By Country/Sub-region
13. Latin America Amniotic Membrane Market Analysis and Forecast
13.1. Introduction
13.2. Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
13.2.1. Cryopreserved Amniotic Membrane
13.2.2. Lyophilization Amniotic Membrane
13.3. Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
13.3.1. Surgical Wounds
13.3.2. Ophthalmology
13.3.3. Others
13.4. Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
13.4.1. Hospitals
13.4.2. Ambulatory Surgical Centers
13.4.3. Specialized Clinics
13.4.4. Research Centers & Laboratories
13.5. Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Amniotic Membrane Market Attractiveness Analysis
13.6.1. By Product
13.6.2. By Application
13.6.3. By End User
13.6.4. By Country/Sub-region
14. Middle East & Africa Amniotic Membrane Market Analysis and Forecast
14.1. Introduction
14.2. Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
14.2.1. Cryopreserved Amniotic Membrane
14.2.2. Lyophilization Amniotic Membrane
14.3. Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
14.3.1. Surgical Wounds
14.3.2. Ophthalmology
14.3.3. Others
14.4. Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
14.4.1. Hospitals
14.4.2. Ambulatory Surgical Centers
14.4.3. Specialized Clinics
14.4.4. Research Centers & Laboratories
14.5. Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
14.5.1. GCC
14.5.2. South Africa
14.5.3. Israel
14.5.4. Rest of Middle East & Africa
14.6. Middle East & Africa Amniotic Membrane Market Attractiveness Analysis
14.6.1. By Product
14.6.2. By Application
14.6.3. By End User
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Share Analysis, by Company, 2018
15.2. Company Profiles
15.2.1. Integra LifeSciences
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Company Financials
15.2.1.3. Growth Strategies
15.2.1.4. SWOT Analysis
15.2.2. MiMedx
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Company Financials
15.2.2.3. Growth Strategies
15.2.2.4. SWOT Analysis
15.2.3. Skye Biologics, Inc.
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Growth Strategies
15.2.3.3. SWOT Analysis
15.2.4. Katena Products, Inc.
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Growth Strategies
15.2.4.3. SWOT Analysis
15.2.5. Amnio Technology, LLC
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Growth Strategies
15.2.5.3. SWOT Analysis
15.2.6. Applied Biologics
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Growth Strategies
15.2.6.3. SWOT Analysis
15.2.7. TissueTech, Inc.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Growth Strategies
15.2.7.3. SWOT Analysis
15.2.8. Stryker
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Company Financials
15.2.8.3. Growth Strategies
15.2.8.4. SWOT Analysis
15.2.9. Osiris Therapeutics, Inc.
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Company Financials
15.2.9.3. Growth Strategies
15.2.9.4. SWOT Analysis
15.2.10. Human Regenerative Technologies, LLC
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Growth Strategies
15.2.10.3. SWOT Analysis
List of Tables
Table 01: Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 02: Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 03: Global Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 04: Global Amniotic Membrane Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 05: North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 06: North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 07: North America Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 08: North America Amniotic Membrane Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 09: Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 10: Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 11: Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 12: Europe Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 13: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 14: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 15: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 16: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 17: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 18: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 19: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 20: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 21: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 22: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Application, 2017–2027
Table 23: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 24: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
List of Figures
Figure 01: Global Amniotic Membrane Market Size (US$ Mn) and Distribution, by Region, 2018 and 2027
Figure 02: Global Amniotic Membrane Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 03: Brand Wise Number of Clinical Trials per Product, 2017
Figure 04: Number of Clinical Trials for Amniotic Membrane Products - Company wise, 2017
Figure 05: Global Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027
Figure 06: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Cryopreserved Amniotic Membrane, 2017–2027
Figure 07: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Lyophilization Amniotic Membrane, 2017–2027
Figure 08: Global Amniotic Membrane Market Attractiveness Analysis, by Product, 2019–2027
Figure 09: Global Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027
Figure 10: Global Amniotic Membrane Value (US$ Mn) and Y-o-Y Growth (%), by Surgical Wounds, 2017–2027
Figure 11: Global Amniotic Membrane Value (US$ Mn) and Y-o-Y Growth (%), by Ophthalmology, 2017–2027
Figure 12: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 13: Global Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027
Figure 14: Global Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027
Figure 15: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027
Figure 16: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017–2027
Figure 17: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Specialized Clinics, 2017–2027
Figure 18: Global Amniotic Membrane Market Value (US$ Mn) and Y-o-Y Growth (%), by Research Centers & Laboratories, 2017–2027
Figure 19: Global Amniotic Membrane Market Attractiveness Analysis, by End User, 2019–2027
Figure 20: Global Amniotic Membrane Market Value Share Analysis, by Region, 2018 and 2027
Figure 21: Global Amniotic Membrane Market Attractiveness Analysis, by Region, 2019–2027
Figure 22: North America Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 23: North America Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027
Figure 24: North America Amniotic Membrane Market Attractiveness Analysis, by Product, 2019–2027
Figure 25: North America Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027
Figure 26: North America Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027
Figure 27: North America Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027
Figure 28: North America Amniotic Membrane Market Attractiveness Analysis, by End User, 2019–2027
Figure 29: North America Amniotic Membrane Market Value Share Analysis, by Country, 2018 and 2027
Figure 30: North America Amniotic Membrane Market Attractiveness Analysis, by Country, 2019–2027
Figure 31: Europe Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 32: Europe Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027
Figure 33: Europe Amniotic Membrane Market Attractiveness Analysis, by Product, 2019–2027
Figure 34: Europe Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027
Figure 35: Europe Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027
Figure 36: Europe Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027
Figure 37: Europe Amniotic Membrane Market Attractiveness Analysis, by End User, 2019–2027
Figure 38: Europe Amniotic Membrane Market Value Share Analysis, by Country/Sub-Region, 2018 and 2027
Figure 39: Europe Amniotic Membrane Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 40: Asia Pacific Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 41: Asia Pacific Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027
Figure 42: Asia Pacific Amniotic Membrane Market Attractiveness Analysis, by Product, 2017–2027
Figure 43: Asia Pacific Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027
Figure 44: Asia Pacific Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027
Figure 45: Asia Pacific Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027
Figure 46: Asia Pacific Amniotic Membrane Market Attractiveness Analysis, by End User, 2019–2027
Figure 47: Asia Pacific Amniotic Membrane Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 48: Asia Pacific Amniotic Membrane Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 49: Latin America Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 50: Latin America Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027
Figure 51: Latin America Amniotic Membrane Market Attractiveness Analysis, by Product, 2019–2027
Figure 52: Latin America Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027
Figure 53: North America Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027
Figure 54: Latin America Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027
Figure 55: Latin America Amniotic Membrane Market Attractiveness Analysis, by End User, 2019–2027
Figure 56: Latin America Amniotic Membrane Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 57: Latin America Amniotic Membrane Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 58: Middle East & Africa Amniotic Membrane Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 59: Middle East & Africa Amniotic Membrane Market Value Share Analysis, by Product, 2018 and 2027
Figure 60: Middle East & Africa Amniotic Membrane Market Attractiveness Analysis, by Product, 2019–2027
Figure 61: Middle East & Africa Amniotic Membrane Market Value Share Analysis, by Application, 2018 and 2027
Figure 62: Middle East & Africa Amniotic Membrane Market Attractiveness Analysis, by Application, 2019–2027
Figure 63: Middle East & Africa Amniotic Membrane Market Value Share Analysis, by End User, 2018 and 2027
Figure 64: Middle East & Africa Amniotic Membrane Market Attractiveness Analysis, by End User, 2019?2027
Figure 65: Middle East & Africa Amniotic Membrane Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 66: Middle East & Africa Amniotic Membrane Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 67: Global Amniotic Membrane Market Share, by Company, 2018
Figure 68: Integra LifeSciences Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 69: Integra LifeSciences Breakdown of Net Sales, by Geography, 2018
Figure 70: Integra LifeSciences Breakdown of Net Sales, by Product Segment, 2018
Figure 71: Integra LifeSciences R&D Intensity and Sales & Marketing Intensity (%), 2015–2018
Figure 72: MiMedx Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 73: Stryker Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 74: Stryker Breakdown of Net Sales (%), by Region/Country, 2018
Figure 75: Stryker Breakdown of Net Sales (%), by Product Segment, 2018
Figure 76: Stryker R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 77: Osiris Therapeutics, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 78: Osiris Therapeutics, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 79: Osiris Therapeutics, Inc. Breakdown of Net Sales (%), by Product Segment, 2017
Complete the form below and we'll get back to you shortly.